Many investors have a great deal of confidence in Bryn Pharma, a Raleigh-based pharmaceutical company that is developing an epinephrine nasal spray to treat anaphylaxis.
To read the full article, visit North Carolina Biotechnology Center.
Facebook
Twitter
Google+
LinkedIn
Pinterest
Stumbleupon
Your email address will not be published. Required fields are marked *
Comment
Name *
Email *